CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 4.5000 |
| Open | 4.6180 |
| Bid | 4.4400 x 100 |
| Ask | 4.4700 x 200 |
| Day's Range | 4.4300 - 5.0600 |
| 52 Week Range | 1.0400 - 5.8500 |
| Volume | |
| Avg. Volume | 4,662,786 |
| Market Cap | 301.745M |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
CytomX Therapeutics (CTMX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Simply Wall St.
Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
CytomX Therapeutics ( NASDAQ:CTMX ) Full Year 2023 Results Key Financial Results Revenue: US$101.2m (up 90% from FY...
© 2024 Yahoo. All rights reserved.